SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-12-010983
Filing Date
2012-11-05
Accepted
2012-11-05 16:04:13
Documents
11
Period of Report
2012-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pdl_8k-110512.htm 8-K 31993
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 133980
3 EXHIBIT 99.2 ex99-2.htm EX-99.2 5079
4 EXHIBIT 99.3 ex99-3.htm EX-99.3 415103
5 a1.jpg GRAPHIC 223583
6 a2.jpg GRAPHIC 313046
7 a3.jpg GRAPHIC 248418
8 a4.jpg GRAPHIC 150007
9 a5.jpg GRAPHIC 227160
10 a6.jpg GRAPHIC 205973
11 logo.jpg GRAPHIC 24317
  Complete submission text file 0001437749-12-010983.txt   2506729
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 121180106
SIC: 2836 Biological Products, (No Diagnostic Substances)